Sponsor or institution

Clinical trials and research at Alkermes, Inc.

• 7Clinical trials
• 1New in 30 days
• 16Countries

Newest trials

All recruiting trials (7)

• ALKS 7290 added to antidepressants for adults with major depression

  This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.

  Recruiting Phase 2 Alkermes, Inc. · Jacksonville, Florida · NCT07901179

• ALKS 7290 vs placebo in adults with ADHD

  This trial tests whether ALKS 7290 can help adults with ADHD better than a placebo.

  Recruiting at 28 sites Phase 2 Alkermes, Inc. · Little Rock, Arkansas and 27 other locations · NCT07755410

• ALKS 2680 in adults with narcolepsy type 1: see if it helps daytime sleepiness and cataplexy

  This study tests whether ALKS 2680 helps reduce daytime sleepiness and cataplexy in adults with narcolepsy type 1 compared with a placebo.

  Recruiting at 20 sites Phase 3 Alkermes, Inc. · Brandon, Florida and 19 other locations · NCT07540897

• ALKS 2680 for adults with Narcolepsy Type 2

  This will test whether ALKS 2680 tablets reduce daytime sleepiness and other symptoms in adults with Narcolepsy Type 2 compared with placebo.

  Recruiting at 43 sites Phase 3 Alkermes, Inc. · Cullman, Alabama and 43 other locations · NCT07502443

• ALKS 2680 for reducing daytime sleepiness and cataplexy in adults with narcolepsy type 1

  This study will test whether ALKS 2680 tablets can reduce daytime sleepiness, cataplexy, and other symptoms in adults with narcolepsy type 1.

  Recruiting at 44 sites Phase 3 Alkermes, Inc. · Cullman, Alabama and 43 other locations · NCT07455383

• Long-term treatment with ALKS 2680 for narcolepsy and idiopathic hypersomnia

  This study is testing how well a new medication called ALKS 2680 works for people with narcolepsy or idiopathic hypersomnia over a long period of time.

  Recruiting at 50 sites Phase 2/3 Alkermes, Inc. · Cullman, Alabama and 49 other locations · NCT06767683

• Evaluating weight gain in children with schizophrenia or bipolar disorder

  This study is testing if a new treatment can help children with schizophrenia or bipolar disorder manage weight gain caused by their current medication.

  Recruiting at 35 sites Phase 3 Alkermes, Inc. · Dothan, Alabama and 46 other locations · NCT05303064

Quick answers

How many clinical trials run by Alkermes, Inc. are recruiting right now?

7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in United States (7 trials), Belgium (4 trials), Canada (3 trials), Japan (3 trials), Australia (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →